论文部分内容阅读
尿激酶为一种纤维蛋白溶解酶，用于血栓症之治疗。其疗效与使用方法和使用时间有关，本文报道应用激酶治疗心肌梗塞患者14名，发病6h内经皮冠状动脉内给药。闭塞的冠状动脉获再通，收到良好效果。14名患者临床症状均符合WHO诊断标准，并作了选择性冠状动脉造影，按TIMI分级其相
Urokinase is a fibrinolytic enzyme used in the treatment of thrombosis. Its efficacy and the use of methods and the use of time, this paper reports the use of kinase therapy in patients with myocardial infarction 14, within 6h of onset of intracoronary administration. Obstructed coronary artery recanalization, received good results. Clinical symptoms of 14 patients were in line with WHO diagnostic criteria, and made a selective coronary angiography, graded according to TIMI phase